Skip to main content
. 2022 Nov 3;38(11):856–862. doi: 10.1089/aid.2022.0029

Table 2.

Physician Preferences for Clinic Visits and Testing Frequency

  Oral agents
Injectable
Subdermal implant
N % n % n %
Visit frequency
 Every 3 months 10 68.8 6 46.2 5 38.5
 Every 6 months 2 12.5 4 30.8 6 46.2
 Annually 0 0.0 0 0.0 2 15.4
 Other 1 7.7 3 23.1 0 0.0
HIV testing frequency
 Every 3 months 11 84.6 8 61.5 6 46.2
 Every 6 months 1 7.7 3 23.1 6 46.2
 Annually 1 7.7 0 0.0 1 7.7
 Other 0 0.0 2 15.4 0 0.0
HIV testing—men who have sex with men
 Every 3 months 12 92.3 9 69.2 11 84.6
 Every 6 months 1 7.7 1 7.7 2 15.4
 Annually 0 0.0 0 0.0 0 0.0
 Other 0 0.0 3 23.1 0 0.0
HIV testing—women who have sex with men
 Every 3 months 9 69.2 7 53.8 8 81.5
 Every 6 months 4 30.8 4 30.8 5 38.5
 Annually 0 0.0 0 0.0 0 0.0
 Other 0 0.0 2 15.4 0 0.0
Renal function testing
 Every 3 months 4 30.8 2 15.4 2 15.4
 Every 6 months 8 61.5 10 76.9 9 69.2
 Annually 1 7.7 1 7.7 2 15.4
Treatment barriers
 Limited insurance coverage 11 84.6 12 92.3 13 100
 High medication cost 9 69.2 10 76.9 10 76.9
 Patient adherence 10 76.9 9 69.2 7 53.8
 Limited pharmacy access to medication 6 46.2 5 38.5 5 38.5
 Consistent management across physicians 5 38.5 6 46.2 5 38.5
 Side effects 3 23.1 4 30.8 6 46.2
 Adverse reactions 1 7.7 2 15.4 2 15.4